Advances in Liposomal Drug Delivery Systems

Abstract

Liposomal drug delivery systems (LDDS) have revolutionized pharmaceutical therapy by enhancing the therapeutic index of drugs through improved pharmacokinetics and targeted delivery. These nanocarriers offer a biocompatible, versatile platform to encapsulate a wide range of bioactive compounds, reducing toxicity and improving bioavailability. Advances in liposomal formulation, including PEGylation, ligand targeting, and stimuli-responsive systems, have further expanded their clinical utility. This review provides a comprehensive overview of modern liposomal technologies and their implications in drug delivery.